Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT06858930

Assessing the Efficacy of a Preoperative Navigation System in Anterior Cruciate Ligament Reconstruction

Led by Beijing Tsinghua Chang Gung Hospital · Updated on 2025-03-05

76

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

Sponsors

B

Beijing Tsinghua Chang Gung Hospital

Lead Sponsor

N

Nanyang Orthopedic Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The ACL surgery robot features a preoperative navigation system that enhances the precision of bone tunnel placement. As the first dual-bundle reconstruction surgical robot developed in China, it integrates advanced technology to ensure accurate anatomical alignment. This multi-center study aims to evaluate the robot's effectiveness in improving surgical outcomes and reducing complications, demonstrating the potential of domestic innovations in orthopedic surgery. With its high accuracy in locating bone tunnel footprints, this robot represents a significant advancement in ACL reconstruction techniques. The trial is designed as a randomized controlled trial (RCT) led by a prospective randomized cohort. The study is initiated by Tsinghua University's long-term professor, Yu Jiakuo, and the product has received China's Class III clinical registration certificate.

CONDITIONS

Official Title

Assessing the Efficacy of a Preoperative Navigation System in Anterior Cruciate Ligament Reconstruction

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Willing and able to sign the informed consent form before surgery
  • Aged 18 to 80 years, any gender
  • Diagnosed with anterior cruciate ligament (ACL) tear without contraindications for implantation
  • Have mature skeletons
  • Able and willing to comply with follow-up visits and observations
Not Eligible

You will not qualify if you...

  • Previously participated in other clinical studies without meeting primary endpoints as required
  • Known allergy to any implanted materials
  • Physically frail or unable to tolerate surgery due to systemic diseases
  • Active infectious lesions in the knee or elsewhere
  • Obesity with a BMI greater than 35
  • Severe diabetes with acute or chronic complications requiring urgent treatment
  • Pregnant or breastfeeding women
  • Drug users or substance abusers
  • Mentally incapacitated or unable to understand study requirements
  • Expected poor compliance or unwillingness to follow postoperative therapy or rehabilitation
  • Other medical conditions limiting study participation or affecting scientific integrity
  • Any other conditions deemed unsuitable by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beijing Tsinghua Chang Gung Hospital.

Beijing, Beijing Municipality, China, 10000

Actively Recruiting

Loading map...

Research Team

J

Jiakuo Yu, Tenured professor at Tsinghua

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here